According to David Bannon, COO and cofounder of Headwall Photonics, the headwall is usually the most difficult part of a mountain climb. It is from this willingness to take on difficult technological challenges, as well as the need for cooperation that climbing entails, that Headwall Photonics takes its name. The company’s prospects have been rising […]
This year, IBO’s top 30 analytical and life science instrument companies shifted in rankings and five new companies were added to the list. The top 30 companies accounted for $20.9 billion in sales during 2006, or approximately 64% of the total $32.8 billion analytical and life science instrument market. Twelve of the 30 companies posted […]
Agilent’s ambitions continue to grow. After a successful 2006 (see IBO 1/15/07), which saw it enter the high-end mass spectrometry (MS) market, the company has set its sights on other market segments. In late March, Agilent announced the formation of a Materials Sciences Solutions Unit (MSSU) within its Life Science and Chemical Analysis (LSCA) business […]
In 1984, Applied Biosystems introduced the first DNA sequencer, revolutionizing genomic analysis. Amersham Biosciences (now GE Healthcare), Beckman Coulter and other companies followed, creating a market estimated at more than $800 million. The most widely used technology for DNA sequencing is a capillary electrophoresis–based (CE) system employing the Sanger method. Although chemistries and automation advances […]
This issue, IBO has made two changes to its Lab Equipment/Consumables Sales Index. Merck KGaA was removed from the Index, while Thermo Fisher Scientific’s Laboratory Products and Services segment was added. Fourth quarter sales for the new Lab Equipment/Consumables Index gained 11.9% to $769 million, while operating profits improved 15.5% to $200 million. Operating margin […]
Despite divergent economic data, all three major indexes managed to gain ground this month. The S&P climbed 1.0%, the Dow Jones rose 0.7% and the NASDAQ increased 0.2%. On March 29, the Commerce Department revised the fourth quarter GDP growth rate from 2.2% to 2.5%. The change was spurred primarily by escalating inventories of unsold […]
If you open the paper, it is hard not to read about a major company establishing manufacturing facilities in a foreign country. Intel’s announcements about facilities in China and Vietnam are recent examples of this phenomenon. Clearly, Asia has been the most attractive region for locating manufacturing facilities for industry in general. However, the instrument […]
Atomic Spectroscopy Bruker AXS also unveiled some important x-ray components, such as the XFlash SDD detector that is now standard on the S2 Ranger and the new version of the MicroStar x-ray source. The MicroStar Ultra can provide a flux of 80 billion x-rays per square millimeter per second, similar to the performance of some […]
Atomic Spectroscopy Bruker AXS, following the acquisition of Quantron (see IBO 9/15/06), released “Brukerized” versions of Quantron’s arc-spark instruments around the first of the year. The Q6 Columbus is a laboratory system, as is the Q8 Magellan, which is priced at about $65,000. The Q8 Coronado (based on the Magellan) is an automated system for […]
Numerous new products are introduced each year at Pittcon. However, Pittcon is not what it used to be for product introductions (see page 4). Thus, while IBO always has plenty of new products to choose from for its annual pick of the top product introductions at the show, Pittcon is not the first exhibition for […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
